DB
ZBH icon

Dmitry Balyasny’s Zimmer Biomet ZBH Stock Holding History

Dmitry Balyasny’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,150
Closed -$635K – 2910
2021
Q4 		$635K Buy
+5,150
New +$674K ﹤0.01% 1563
2020
Q4 		– Sell
-41,200
Closed -$5.45M – 1771
2020
Q3 		$5.45M Buy
41,200
+10,300
+33% +$1.35M 0.04% 580
2020
Q2 		$3.58M Buy
+30,900
New +$3.56M 0.03% 600
2017
Q4 		– Sell
-190,550
Closed -$21.7M – 2367
2017
Q3 		$21.7M Sell
190,550
-236,900
-55% -$27.3M 0.08% 305
2017
Q2 		$53.3M Buy
+427,450
New +$50.7M 0.22% 109
2015
Q2 		– Sell
-51,500
Closed -$5.88M – 1360
2015
Q1 		$5.88M Buy
+51,500
New +$5.88M 0.05% 449

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dmitry Balyasny's ZBH Position: Q2 2026 in Review

Dmitry Balyasny sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 424,578 shares — an estimated $38.4M sold.

Dmitry Balyasny first reported a position in ZBH in Q3 2013 and held it in 40 quarters. The position peaked at $124M in Q3 2022. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Dmitry Balyasny reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 424,578 Zimmer Biomet shares in Q2 2026, an estimated $38.4M.
  • Dmitry Balyasny first reported a position in Zimmer Biomet in Q3 2013 and held it in 40 quarters.
  • Dmitry Balyasny's Zimmer Biomet position peaked at $124M in Q3 2022.
  • 904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.